UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RETA holding history

Reata Pharmaceuticals Inc in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RETA overview All 13F holders of RETA Full Q4 2025 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of RETA by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−5,000−100.0%	Sold out	Holders
Q2 2023	5,000	$509.8K	<0.1%	−250−4.8%	Reduced	Holders
Q1 2023	5,250	$477.3K	<0.1%	+5,250	New	Holders